Gene · 55509
BATF3: basic leucine zipper ATF-like transcription factor 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. BATF3: basic leucine zipper ATF-like transcription factor 3. Genes, record 55509. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55509
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NR55 | Basic leucine zipper transcriptional factor ATF-like 3 | 127 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents61
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 38629 | Q9NR55 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 767 | Q9NR55 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4412 | Q9NR55 | Espacenet |
| JP 2025156332 A | 2025-10-14 | 5 | Q9NR55 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14788 | Q9NR55 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 767 | Q9NR55 | Espacenet |
| WO 2025120097 A1 | 2025-06-12 | 22 | Q9NR55 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8368 | Q9NR55 | Espacenet |
| JP 2025506185 A | 2025-03-07 | 32 | Q9NR55 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 14788 | Q9NR55 | Espacenet |
1 to 10 of 61
See all 61 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,271
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BATF3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 14 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 11 | 2025 |
| R35CA210098 | Overcoming resistance to anti-PD1 immunotherapy | 9 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 6 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 6 | 2025 |
| P30CA016520 | Abramson Cancer Center Support Grant | 6 | 2025 |
| U19AI128949 | Human anti-viral immune responses in tissues and circulation | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| R01CA154947 | Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis | 5 | 2025 |
| T32AI007090 | Interdisciplinary Training Program in Immunology | 5 | 2025 |
1 to 10 of 1,271Source NIH's project files
See all 1,271 nih grantsPapers1,335
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Real-world insights into genomic reprogramming during CAR-T cell manufacturing in India. | Front Immunol | 2026 | 42756106 | PubTator, text mining | PubMed |
| Dendritic cell centric nanoengineering couples antigen acquisition and STING activation for cancer immunotherapy. | Cell Rep Med | 2026 | 42705236 | PubTator, text mining | PubMed |
| CRISPRa-identified transcription factors reprogram glioblastoma into dendritic cell-like cells to elicit systemic antitumor immunity. | Cell Rep Med | 2026 | 42679804 | PubTator, text mining | PubMed |
| Clinical translation of epigenome editing technologies. | Curr Opin Biomed Eng | 2026 | 42582990 | PubTator, text mining | PubMed |
| Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression. | Leukemia | 2026 | 42533032 | PubTator, text mining | PubMed |
| The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity. | Science | 2026 | 42424445 | PubTator, text mining | PubMed |
| Temporal changes in gene regulation during human tissue repair. | Sci Rep | 2026 | 42259926 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals a persistent interferon signature in immune cells from systemic lupus erythematosus patients with high versus low polygenic risk scores despite antimalarial treatment. | J Autoimmun | 2026 | 42119160 | PubTator, text mining | PubMed |
| What Is-and What Is Not-Immunogenic Cell Death? Functional Definitions, Experimental Standards, and Common Pitfalls. | Int J Mol Sci | 2026 | 41977247 | PubTator, text mining | PubMed |
| BATF3 regulates differentiation of CD8+ T lymphocytes and memory differentiation program. | Life Sci Alliance | 2026 | 41974573 | PubTator, text mining | PubMed |
1 to 10 of 1,335
See all 1,335 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55509
GET https://conductscience.org/api/genes/v1/55509/patents?page=2